BRIM-3 trial in melanoma: prognostic factors of overall survival and the issue of salvage therapies
Issues with treating late cancer effects from pediatric cancer
How can mutations in stem cells be treated?
Supportive care improvement needs for indigenous communities
Jasmine Micklem et al.
BRAF mutated melanoma: targeted or immunotherapy?
Rodabe N. Amaria